A 2019 policy resolution that calls for the AAFP to support the safety and efficacy of mifepristone as the most evidence-based care for medical management of early pregnancy loss and to reaffirm its efforts to overturn restrictions on the prescribing of Mifepristone, especially considering data supporting its use in early pregnancy loss.
A substitute resolution was adopted by the 2019 Congress of Delegates.
A 2019 policy resolution that calls for the AAFP to support ensuring coverage of all Food and Drug Administration-approved contraceptive drugs, devices, and products as well as voluntary sterilization procedures by private and public entities as part of a minimum benefits plan. The resolution was reaffirmed as current policy by the 2019 Congress of Delegates.
IUDs are typically removed by clinicians during a pelvic exam in the office. There can be numerous barriers to this arrangement, such as difficulty scheduling an appointment, concern about appointment cost, and clinician refusal of patient’s request for removal. Unsurprisingly, these barriers can raise patients’ concerns about ability to retain control over their own reproductive…
Premenstrual syndrome (PMS) is a combination of physical and emotional symptoms that begin after ovulation and resolve within the first 4 days of menstruation. Over 90% of women experience PMS at some point during their reproductive years, and approximately 5% of women experience the more severe premenstrual dysphoric disorder (PMDD). PMS symptoms include irritability, fatigue,…
Natural Family Planning (NFP) methods, also known as Fertility Awareness, help women track their fertile and non-fertile days. This Contraceptive Pearl discusses Natural Planning Methods, their efficacy and important considerations.
The Affordable Care Act mandates free birth control pills for most patients with health insurance. However, uninsured people and many people with a religious employer don’t benefit from this policy. For uninsured and underinsured people, access to affordable contraception is difficult. Fortunately, there are several ways for clinicians to help patients get birth control pills…
Payment Assistance Programs: DepoProvera (Progestin Injection) Pfizer Patient Assistance Program: Provides injected progestin, intramuscular for office administration and subcutaneous for home administration. IUDs (Intrauterine Devices) ARCH Foundation: Patient Assistance Program for Mirena, Kyleena, and Skyla IUDs Liletta Patient Savings Program ParaGard Patient Assistance Program Oral Contraceptive Pills 340B Drug Pricing Program: Offers birth control pills…
There are 3 mainstays of treatment for emergency contraception: copper IUD, ulipristal acetate, and levonorgesterel. Emergency contraception prevents pregnancy after unprotected sex; it does NOT end a pregnancy and will not work if the patient is already pregnant. *May be cheaper with 340B pricing or the Paragard Patient Assistance Program. The copper IUD is the…
Though IUDs are among the most effective forms of contraception, some patients and providers are often deterred from this option due to fear of painful insertion. Lidocaine spray, gel, and 1% lidocaine paracervical block have been utilized as methods of pain reduction with IUD insertion; research shows that some methods may be more effective than…